Navigation Links
Alexza Pharmaceuticals Promotes Peter D. Noymer, PhD to Vice President, Product R&D
Date:3/2/2009

MOUNTAIN VIEW, Calif., March 2 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that Peter D. Noymer, PhD has been promoted to Vice President, Product Research & Development. In this new position, he will have oversight responsibilities for device engineering, product development and pharmaceutical development for Alexza's technology programs.

Dr. Noymer joined Alexza in 2006 and was most recently Senior Director, Product Research & Development. From 1999 to 2006, Dr. Noymer held various management positions at Aradigm Corporation, developing drug delivery combination products for both inhalation and injection. Prior to joining Aradigm, he held an appointment as Visiting Assistant Professor at Carnegie Mellon University, as well as various engineering positions at General Electric. Dr. Noymer received MS and PhD degrees in mechanical engineering from MIT, and a BS degree in mechanical & aerospace engineering from Princeton University.

"We are very pleased to announce Peter's promotion and welcome him to our management team," said James V. Cassella, PhD, Senior Vice President, Research & Development. "Peter and the Product R&D team have made significant contributions to Alexza's technology base and product pipeline, and we look forward to leveraging his leadership and experience in product development as Alexza moves rapidly toward commercialization of its products."

About Alexza Pharmaceuticals, Inc.

Alexza Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The Company's technology, the Staccato(R) system, vaporizes unformulated drug to form a condensation aer
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Alexza to Initiate the First Phase 3 Trial for AZ-004 (Staccato(R) Loxapine) in Late Q1 2008
2. Alexza and Autoliv Announce Commercial Manufacturing and Supply Agreement for Heat Packages Used in Single-Dose Staccato(R) System
3. Alexzas Corporate Presentation to be Webcast at the Cowen & Company 28th Annual Health Care Conference
4. Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
5. Alexza to Webcast Investor and Analyst Day Presentations
6. Alexzas Corporate Presentation to be Webcast at the Seventh Annual JMP Securities Research Conference and the 2008 Citi Investment Research Global Healthcare Conference
7. Carlos A. Parra Joins Alexza Pharmaceuticals as Vice President, Quality
8. Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
9. Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
10. Alexza to Announce 2008 Third Quarter Financial Results and Update Its Clinical Pipeline on Thursday, November 6, 2008
11. Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2015)... ... August 30, 2015 , ... Nutritional Products ... Administrative assistant to Executive Assistant to CEO Mitch Gould for Nutritional Products International. ... on your goals. Kathleen graduated from Florida State University with a Bachelor ...
(Date:8/29/2015)... ... 30, 2015 , ... Electronic Informed Consent for Clinical Trials:, ... EDT, http://www.fdanews.com/electronicinformedconsent , The simple fact about electronic informed consent is ... Clinical trial sites can now use audio, video and interactivity to educate participants ...
(Date:8/29/2015)... ... August 29, 2015 , ... Targeted therapies, made ... the lives of patients, according to a newly published report. Surviving Mesothelioma has ... full article. , The authors of the new paper focus on several ...
(Date:8/29/2015)... ... ... ProDrop Particles includes over 40 particle backdrops designed for use in ... users can shrink and stretch in the Final Cut Pro X timeline. Choose from ... scale, speed, range, and flare attributes with intuitive controls found in the top-right inspector ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... to freely market and sell Arterosil and Arterosil HP, and that all claims ... (DHS) sued Vascular Health Sciences, LLC (VHS) in the United States District Court ...
Breaking Medicine News(10 mins):Health News:NPI Appoints New Executive Assistant To CEO 2Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 2Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 3Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 4Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2
... 2009 in TEDA Tianjin, ChinaTEDA Tianjin, China, May 20 ... of API,s and intermediates, and Drug Products to the ... its high potency Active Pharmaceutical Ingredient (API) and Drug ... facility is sited at Asymchem,s TEDA Tianjin 1 location, ...
... Annual award honors the accomplishments of medical education professionals in Texas. ... ... -- TIAA-CREF, a national financial services group and the leading provider ... announced today that it is soliciting statewide nominations for the 2009 ...
... today that three influential independent proxy voting advisory services, RiskMetrics ... recommended that stockholders of Amylin Pharmaceuticals, Inc. (Nasdaq: ... of Directors of Amylin,s at the 2009 Annual Meeting of ... RiskMetrics Group has recommended that Amylin stockholders ...
... N.Y., May 20 VirtualScopics, Inc. (Nasdaq: ... clinical trials, today announced that it has received notification ... compliance with the minimum $1.00 per share bid price ... other applicable standards for continued listing. To regain compliance ...
... , The ghrelin hormone not only stimulates the ... favours the accumulation of lipids in visceral fatty tissue, located ... harmful. This is the conclusion of research undertaken at Metabolic ... in the International Journal of Obesity . , Ghrelin ...
... over 150 scientific studies: Balanced organic diet before and ... The Organic Center (TOC), a leading research institute ... announced today that a balanced, organic diet -- both ... child,s likelihood of being overweight, obese or developing diabetes. ...
Cached Medicine News:Health News:Asymchem Announces Opening of High Potency API and Drug Product Facility 2Health News:Open Call for Nominations for the Sixth Annual TIAA-CREF Distinguished Medical Educator Award 2Health News:Open Call for Nominations for the Sixth Annual TIAA-CREF Distinguished Medical Educator Award 3Health News:Open Call for Nominations for the Sixth Annual TIAA-CREF Distinguished Medical Educator Award 4Health News:Three Independent Proxy Advisory Firms Support Stockholder Nominees in Amylin Proxy Fight 2Health News:Three Independent Proxy Advisory Firms Support Stockholder Nominees in Amylin Proxy Fight 3Health News:VirtualScopics Regains NASDAQ Compliance 2Health News:Action of ghrelin hormone increases appetite and favors accumulation of abdominal fat 2Health News:Action of ghrelin hormone increases appetite and favors accumulation of abdominal fat 3Health News:Studies Reveal Exposure to Pesticides During Pregnancy Increases Risk of Premature Birth, Low-Birth Weight, Neurological Problems and Diabetes 2Health News:Studies Reveal Exposure to Pesticides During Pregnancy Increases Risk of Premature Birth, Low-Birth Weight, Neurological Problems and Diabetes 3
(Date:8/28/2015)... Aug. 28, 2015  Today, in final recognition of ... Lens Health Week, 1-800 Contacts is sharing how to ... contact lens wearers who do not properly care for ... eye infections. Most contact lens wearers ... a clean lens case is sometimes overlooked.  When proper ...
(Date:8/28/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/rktnl9/investigation ... "Investigation Report on China,s Insulin Aspart Market, 2010-2019" ... by Novo Nordisk, insulin aspart (under the trade ... the treatment of diabetes. Compared with human insulin, ... starts working fast and reports higher peak of ...
(Date:8/28/2015)... , August 28, 2015 The scientific ... collaboration with one of the leading academics in the field ... world record holder in life extension for model animals - ... biology of aging and age-related diseases, primarily, around the stability ... has just been published as "Stability analysis of a model ...
Breaking Medicine Technology:1-800 Contacts Shares Tips on How to Clean Lens Cases 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3
Full Handle Laseredge Stab Blade Knife, 22.5 blade. Blade tip dimension: 10.7 mm x 1.8 mm x 4.2 mm....
18 gauge straight. Fine tip. Lightweight design offers precise hemostasis. Pencil design minimizes tissue trauma and induced astigmatism. Knurled handle provides a sure grip and better manipulation....
Sharp tip with cutting edge bent to 45 degrees. Fits 19 gauge or 20 gauge instrument port. 21 gauge x 25 mm. 10 per box....
80 inch PVC tubing with connectors and 19 gauge straight, beveled cannula. Fits Bausch & Lomb Surgical cassettes. Allows the safe removal of silicone oil in 10 minutes or less. 3/Box...
Medicine Products: